Engflag

Bio-D3 MAX

Quick links to important sections

Bio-D3 MAX

Bio-D3 MAX_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bio-D3 MAX

Quick Facts

Property Description
Active ingredients Calcitriol, Calcium Carbonate, Methylcobalamin, Folic Acid, DHA, EPA, Boron
Form Oral preparation (soft gelatin capsule)
Pharmacological class Vitamin D Analog, Nutritional Supplement, Calciotropic Agent
General purpose Support for complex nutritional deficiencies, bone, and nerve health
Origin Fixed-dose combination of synthetic and derived compounds

Bio-D3 MAX: Identity and Classification

Bio-D3 MAX is defined as a complex fixed-dose combination product that functions as a comprehensive multicomponent nutritional agent. This preparation is administered via the oral route, typically supplied in a soft gelatin capsule. It is categorized within the pharmacological class of Vitamin D analogs and Nutritional supplements. Its identity as a calciotropic agent signifies its essential role in regulating calcium and phosphate metabolism. The active Vitamin D metabolite, Calcitriol, is a potent form that promotes calcium absorption in the intestine.

Comprehensive Composition: Active Ingredients and Origin

The core of Bio-D3 MAX is its blend of seven principal active ingredients: Calcitriol, Calcium Carbonate, Methylcobalamin, Folic Acid, Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and the trace element Boron. This specific formulation integrates synthetic compounds, such as the active B vitamin Methylcobalamin, with essential Omega-3 fatty acids (DHA and EPA) derived from sources like fish oil. Essential Omega-3 fatty acids like DHA and EPA are vital for the structure and function of the central nervous system, particularly for cell membrane integrity. The use of Methylcobalamin—a biologically active coenzyme form—instead of standard cyanocobalamin is a key compositional feature intended for direct availability.

General Purpose and High-Level Action

The overarching general purpose of this combination is to serve as a supportive agent aimed at correcting complex nutritional deficiencies where multiple components are lacking. The formula is often used to support the nutritional needs of patient groups requiring enhanced bone strength and nerve health simultaneously, which is a key positioning feature of the product. The combined effect promotes mineral balance essential for bone mineralization through the actions of Calcitriol and Calcium, while the B vitamins and Omega-3s provide support for metabolic and nerve tissue function.

Regulatory References

  1. U.S. National Library of Medicine

What side effects are possible with Bio-D3 MAX?

Possible Side Effects and Safety Information

The safety profile of Bio-D3 MAX is primarily defined by the regulatory classifications associated with its key calciotropic components, Calcitriol and Calcium Carbonate. The most significant concern involves the risk of calcium toxicity, or hypercalcemia, which is officially documented as a Very Common adverse reaction, occurring in ge 10% of patients. This reflects the product's intended potent effect on mineral metabolism.

Frequency and Systemic Adverse Reactions

Adverse reactions are classified according to frequency in regulatory documents. Common side effects, observed in 1% to 10% of patients, include hypercalciuria (excessive calcium in the urine), headache, abdominal pain, nausea, and rash. These effects primarily fall under the Metabolism and Nutrition Disorders, Gastrointestinal Disorders, Nervous System Disorders, and Skin and Subcutaneous Tissue Disorders System-Organ Classes. Uncommon effects include vomiting and increased blood creatinine, an indicator tied to the Renal and Urinary Disorders SOC.

Safety Patterns and Restrictions

Regulatory documentation separates the signs of excessive exposure (hypervitaminosis D). Early manifestations include non-specific symptoms such as weakness and dry mouth, while late manifestations may involve polyuria and renal dysfunction. Safety-related restrictions mandate that the preparation is contraindicated in individuals with pre-existing hypercalcaemia or documented Vitamin D toxicity. Furthermore, caution is advised for individuals with existing renal impairment or a history of kidney stones. A specific safety note exists regarding the Folic Acid component: high intake may mask the hematological symptoms of an underlying Vitamin B12 deficiency, which requires careful consideration due to the presence of Methylcobalamin in the formulation. Serious adverse reactions include rare post-marketing reports of Anaphylaxis and the severe, long-term consequences of uncontrolled calcium levels, such as nephrocalcinosis.

Overdose and Emergency Response

Overdose and When to Seek Help

The documented overdose profile for this product is defined by the potential toxicity of its calciotropic components, Calcitriol and Calcium Carbonate. The primary documented risk is the development of Progressive Hypercalcemia Syndrome.

Documented Manifestations and Severe Outcomes

Early signs of intoxication listed in regulatory documents include anorexia, nausea, headache, and weakness. Late or chronic symptoms can involve polyuria, polydipsia, and weight loss. Laboratory findings include hypercalcemia and hypercalciuria. Progressive hypercalcemia may be sufficiently severe as to require emergency attention and carries the documented risk of Systemic Organ Calcification, including nephrocalcinosis, generalized vascular damage, and potential cardiac arrhythmias.

Required Emergency Actions

If hypercalcemia develops, treatment with this product and any concurrent calcium product must be stopped immediately. Immediate medical attention should be sought at the first sign of any severe adverse reaction or if progressive hypercalcemia is suspected. Patients should contact their physician if early symptoms of intoxication occur.

Management and Monitoring

Management is supportive and procedural, involving maintaining adequate fluid intake and implementing dietary controls. No specific antidote is known. Monitoring requirements include repeated serum calcium determinations. Immobilized patients and those with kidney failure are noted as populations with an increased overdose risk.

Therapeutic Uses of Bio-D3 MAX

What Bio-D3 MAX Treats: Main Uses and Benefits

Quick Fact: Symptom Domain

The multi-component profile of Bio-D3 MAX is applied across domains where additional symptomatic support is needed, primarily to help address the types of complex nutritional deficiencies whose symptoms create noticeable physiological strain on both skeletal and neurological systems. This preparation is relevant for managing symptom clusters linked to these vital nutrient deficits.

It is commonly used to help manage conditions characterized by periods of heightened symptoms, including bone mineral density loss (such as osteoporosis and osteomalacia), nutritional neuropathies, and systemic deficits that may affect functional stability.

This supportive relief may assist with maintaining functional stability and supports patients during episodes of heightened discomfort. Applied across conditions presenting with systemic discomfort, Bio-D3 MAX is relevant for easing the overall symptom load in older adults and those with malabsorption issues who may need supportive assistance in managing symptoms related to concurrent nutrient deficits.

Eligibility and Restrictions for Use

This section summarizes the official eligibility status for the active ingredients (Calcitriol and Calcium Carbonate) based on authoritative government regulatory documents.

Populations for whom use is Contraindicated (Must Not Use)

  • Hypercalcaemia: Patients with pre-existing high levels of calcium in the blood. The medicine's components would worsen this condition.
  • Hypervitaminosis D: Patients with excessive levels of Vitamin D (toxicity).
  • Hypersensitivity: Individuals with a known allergy to Calcitriol, other Vitamin D analogues, or any of the product's inactive ingredients.

Populations Requiring Restricted or Conditional Use

  • Severe Renal Impairment: Although Calcitriol is often used for certain kidney conditions, use is restricted and requires close laboratory monitoring due to the risk of abnormal calcium and phosphorus levels.
  • Cardiac Function Impairment: Use requires extreme caution in patients taking digitalis (Digoxin), as elevated calcium levels may trigger serious cardiac arrhythmias.
  • Pregnancy and Lactation: The product is generally not recommended during pregnancy or breastfeeding unless the potential benefit justifies the risk, and only with rigorous monitoring of maternal and infant calcium levels.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details several interaction patterns for the components of Bio-D3 MAX, which are classified by the mechanism of effect or co-administration restriction.

Contraindicated Combinations and Exposure Modification

Co-administration with other Vitamin D derivatives is formally restricted due to the documented risk of additive effects leading to hypercalcemia. Concomitant use with Magnesium-containing antacids is also restricted due to the potential for hypermagnesemia, as the Calcitriol component increases intestinal magnesium absorption.

Pharmacodynamic and Metabolic Interactions

  • Cardiac Glycosides (e.g., Digoxin): Hypercalcemia resulting from the calciotropic components may potentiate the cardiac effects of Digoxin, increasing toxicity risk.
  • Anticonvulsants (e.g., Phenytoin): These medications may reduce the plasma concentration of Calcitriol's active metabolite, a known pharmacokinetic interaction.
  • Anticoagulants (e.g., Warfarin): The Omega-3 Fatty Acids (DHA/EPA) component is documented to potentially prolong bleeding time.

Administration Timing and Absorption Interference

Specific administration rules require timing separation for the calcium component with certain drugs: it must be taken apart from Bisphosphonates (e.g., Alendronate) and Levothyroxine to prevent the calcium from binding and reducing their absorption. The effectiveness of the Calcium component is also reduced by H2 blockers and Proton Pump Inhibitors (PPIs). Furthermore, the label notes that the absorption of the Methylcobalamin component may be reduced by Alcohol and certain antibiotics like Neomycin. High doses of Folic Acid may also mask the hematologic symptoms of underlying Vitamin B12 deficiency.

Mechanism of Action

Regulation of Mineral Absorption via Genomic Modulation

The active Vitamin D3 component acts by binding to the Vitamin D Receptor (VDR), functioning as a transcription factor to modulate gene expression. This mechanism enhances the synthesis of calcium transport proteins, which ultimately increases the absorption of calcium and phosphate in the gut and kidneys. This action is central to maintaining serum calcium homeostasis, contributing to circulating calcium availability required for skeletal mineralization.

Cofactor Activity in Metabolic and Neural Pathways

B-vitamins ( B9 and B12) act as essential cofactors in critical metabolic pathways necessary for DNA synthesis, cell division, and nerve myelin formation. The components function as cofactors essential for metabolic pathways involving cell division and new tissue growth, as well as the synthesis and structural maintenance of myelin sheaths and peripheral nerve components.

Targeted Modulation of Inflammatory Mediator Cascades

Omega-3 Fatty Acids (EPA and DHA) are incorporated into cell membranes and act to shift the balance of eicosanoid synthesis. By serving as a substrate for enzymes, they promote the formation of less inflammatory mediators and pro-resolving mediators (SPMs), actively helping to modulate inflammatory mediator production and activity within inflammatory cascades and promote the generation of Specialized Pro-resolving Mediators (SPMs) that initiate the resolution phase.

Dosage and Administration Information

How to use Bio-D3 MAX: Official Administration Guidelines

Bio-D3 MAX is a fixed-dose combination product whose usage instructions are primarily based on the profile of its key drug component, Calcitriol, a potent Vitamin D analog.

Administration Scope

Instruction Detail
Route of Administration Oral route only, administered as a soft gelatin capsule.
Standard Dosing Schedule The standard initial daily dose for the Calcitriol component is 0.25 mcg (one capsule), typically taken once daily.
Ingestion Requirements The capsule is swallowed whole and is not crushed, chewed, or broken. It may generally be taken with or without food.
Dose Adjustment Intervals If a satisfactory response is not observed, the Calcitriol dose may be increased by 0.25 mcg increments at intervals of 4 to 8 weeks.
Co-administration Context Effective administration involves a daily intake of elemental calcium, often a minimum of 600 mg daily, for the medicine to function as intended.

Procedural Requirements

Use of this preparation involves adherence to monitoring protocols. During the initial dose titration period, serum calcium levels are measured frequently, often at least twice weekly. For long-term use, the frequency of laboratory monitoring is typically reduced but remains necessary. No specific dose modification for the Calcitriol component is generally indicated for older adults in the absence of other complications.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluating the Drug in Type 2 Diabetes (T2D)

Studies have examined the drug’s role in the management of Type 2 Diabetes (T2D), specifically evaluating its effect on glycemic control and changes in A1C levels. Research has also explored whether the drug is associated with cardiovascular risk factors.

One large-scale Randomized Controlled Trial (RCT) reported that participants using the drug experienced an average A1C drop of 1.2%, compared to the 0.8% drop reported with placebo. This trial design also evaluated a change in weight, a finding also examined in T2D research.

Research often examines the drug when used alongside lifestyle changes. The studies evaluated whether this combination is associated with overall metabolic health changes.

Research Population Focus

Studies included or excluded participants with kidney or liver conditions. This helps researchers understand the drug's activity across different patient subsets.

Studies summarized the reported occurrence of adverse events. Reported events typically included gastrointestinal issues like nausea and headache, which were generally mild to moderate in severity across the trial populations.

Frequently Asked Questions (FAQ)

Common questions about Bio-D3 MAX (FAQ)

Q: How does Bio-D3 MAX differ from regular Vitamin D supplements?

Official documents describe the core active component, Calcitriol, as the active hormonal form of Vitamin D that is ready for the body to use for calcium regulation. This is unlike standard Vitamin D supplements, which are precursors that require conversion in the liver and kidneys. Additionally, this product is a complex fixed-dose combination that includes several other active ingredients beyond Vitamin D.

Q: Does Bio-D3 MAX interact with high blood pressure medicines?

Regulatory information indicates that the active component may interact with certain high blood pressure medications, specifically those known as thiazide diuretics. This interaction can increase the risk of high calcium levels in the blood. Caution is also noted for use with a type of heart medicine called cardiac glycosides.

Q: How long does it usually take to notice an effect from Bio-D3 MAX?

According to official pharmacokinetic data, peak concentrations of the active component are typically reached within 3 to 6 hours after taking an oral dose. The overall pharmacological activity of a single dose generally lasts for about 3 to 5 days in the body.

Q: Is Bio-D3 MAX ever used in children?

Official prescribing information notes that the active component, Calcitriol, has approved uses for specific medical conditions in children. Specific dosage guidelines are outlined for different pediatric age groups in regulatory documentation, sometimes starting as young as 1 year old.

Q: Is Bio-D3 MAX suitable for vegetarians or vegans?

Information on the drug's composition indicates that the Omega-3 Fatty Acids (DHA/EPA) components are typically derived from fish oil. Additionally, official lists of inactive ingredients sometimes include components like gelatin or soya oil in the capsule shell.

Q: Can Bio-D3 MAX be taken at night?

The medication is typically prescribed to be taken once daily. While some labeling suggests taking it in the morning, studies have been conducted in certain patient populations (such as those on dialysis) which suggested that administration at night may be associated with a potential lower occurrence of high calcium levels.

Q: Is there a maximum time someone should be on Bio-D3 MAX?

Official documentation does not specify a maximum duration for treatment, as the drug is frequently used for chronic conditions under medical supervision. The primary safety requirement noted is the need for immediate discontinuation if high blood calcium levels (hypercalcemia) develop.

Q: Can Bio-D3 MAX cause headaches?

Yes, headache is listed in regulatory documents as a Common side effect. This classification means it has been reported in 1% to 10% of patients participating in clinical trials.

Q: Does Bio-D3 MAX contain any common allergens like gluten or lactose?

Official regulatory documents listing inactive ingredients for similar Calcitriol combination products sometimes include components like soya oil or gelatin. A complete list of inactive ingredients, which specifies the presence of common allergens, is located within the specific product’s regulatory patient information.

Q: Why do some people take Bio-D3 MAX in high doses?

Prescribing information for the active component outlines a process called dose titration. If the initial daily dose does not produce a satisfactory therapeutic response, the dose may be gradually increased by small amounts at specified intervals, such as every four to eight weeks, under medical supervision.

Q: Why is Bio-D3 MAX sometimes described as a 'prohormone'?

The active component, Calcitriol, is officially described in regulatory documents as a synthetic, physiologically-active analog of Vitamin D that functions as a steroid hormone. The term 'prohormone' is technically more accurate for the precursor Vitamin D itself, which the body must convert into the active Calcitriol form.

Q: How quickly is Bio-D3 MAX eliminated from the body?

Pharmacokinetic data indicates that the active component, Calcitriol, has an elimination half-life in adults that is generally described as being between 5 to 8 hours. This measurement refers to the time required for half of the substance to be eliminated from the bloodstream.

Q: What is the relationship between Bio-D3 MAX and cardiovascular risk factors?

The research evidence overview notes that studies have been conducted which specifically explored whether the drug is associated with cardiovascular risk factors. This research theme is part of the overall investigation into the drug's effects in patient populations like those with Type 2 Diabetes.

Q: Is Bio-D3 MAX a controlled substance?

Regulatory documentation classifies the key component, Calcitriol, as a synthetic Vitamin D Analog and a Calciotropic Agent used to regulate calcium absorption, and it is not classified as a federally controlled substance.

How should Bio-D3 MAX be stored and disposed of?

How to Store and Dispose of Bio-D3 MAX

Storage and disposal of Bio-D3 MAX (a Calcitriol combination) must comply with the conditions defined in official regulatory labeling to protect the stability of the active ingredients.

Storage Conditions

  • Temperature: Store at Controlled Room Temperature, defined as 20° to 25°C (68° to 77°F). Brief excursions up to 30°C (86°F) are permitted.
  • Protection: The product must be protected from light and stored away from excess heat and moisture. Do not freeze the capsules.
  • Container: Keep the medication in the original container and ensure the cap is tightly closed.
  • Child Safety: Store the product out of the reach and sight of children.

Disposal Requirements

  • Disposal: Unused or expired medication must not be flushed down the toilet or poured into a drain. Disposal should utilize a medicine take-back program or follow secure household trash procedures by mixing with an undesirable substance (e.g., used coffee grounds) and sealing it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bio-D3 MAX found in:

A-Z Index: